Extending Progression-Free Survival: Osimertinib as First Line Treatment for Lung Cancer
Receiving a non-small cell lung cancer (NSCLC) diagnosis is overwhelming. Learning your tumor has a specific EGFR mutation adds another layer of complexity. Standard chemotherapy …
